ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 253 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,307,890 | -38.0% | 423,466 | -23.7% | 0.00% | -33.3% |
| Q2 2023 | $3,722,554 | -32.3% | 554,777 | -10.9% | 0.00% | -40.0% |
| Q1 2023 | $5,497,902 | +14.1% | 622,639 | -1.3% | 0.01% | 0.0% |
| Q4 2022 | $4,819,839 | +17.2% | 630,869 | +9.2% | 0.01% | +25.0% |
| Q3 2022 | $4,113,000 | -2.0% | 577,659 | +11.4% | 0.00% | 0.0% |
| Q2 2022 | $4,195,000 | -76.2% | 518,556 | -59.1% | 0.00% | -73.3% |
| Q1 2022 | $17,601,000 | -68.6% | 1,268,073 | -36.7% | 0.02% | -65.9% |
| Q4 2021 | $56,143,000 | -26.6% | 2,002,644 | -11.1% | 0.04% | -34.3% |
| Q3 2021 | $76,537,000 | -14.7% | 2,253,728 | +2.4% | 0.07% | -14.1% |
| Q2 2021 | $89,752,000 | +6.0% | 2,201,885 | +4.7% | 0.08% | -3.7% |
| Q1 2021 | $84,638,000 | -28.7% | 2,102,745 | +4.7% | 0.08% | -34.1% |
| Q4 2020 | $118,789,000 | +32.2% | 2,009,304 | +8.7% | 0.12% | +15.0% |
| Q3 2020 | $89,871,000 | +7.8% | 1,847,952 | +7.2% | 0.11% | +2.9% |
| Q2 2020 | $83,389,000 | +503.0% | 1,723,347 | +246.2% | 0.10% | +395.2% |
| Q1 2020 | $13,830,000 | – | 497,845 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |